Guest commentary: New facts about the gut microbiome that may be surprising

July 23, 2019
In this guest commentary, Samantha Nazareth, MD, FACG, a gastroenterologist in private practice, offers several take-home messages

FDA clears LPCN 1144 investigative NASH therapy for expanded trials

July 23, 2019
Lipocine received clearance from the FDA to clinically investigate LPCN 1144 in an expanded target population of men with nonalcoholic…
Breaking News

Senators announce bipartisan plan to lower drug prices

July 23, 2019
Two lawmakers introduced legislation today that they said would lower the price of prescription drugs for Americans, according to a press release. …
In the Journals

USPSTF: Screen pregnant women for hepatitis B

July 23, 2019
The U.S. Preventive Services Task Force recently gave an ‘A’ level recommendation to screening women for hepatitis B in their first…
FDA News

FDA grants breakthrough therapy designation to Keytruda-Lenvima combination for hepatocellular carcinoma

July 23, 2019
The FDA granted breakthrough therapy designation to pembrolizumab in combination with lenvatinib as first-line treatment for patients with advanced…
In the Journals

Outpatient VTE linked with age, C. diff, discharge after IBD hospitalizations

July 23, 2019
Patients with inflammatory bowel disease are at increased risk for venous thromboembolism for up two months after discharge from the hospital…

$1.4 billion settlement against opioid manufacturer puts spotlight on generic drugs, treatment gaps

July 23, 2019
The lawsuit involving the manufacturer of Suboxone film that was settled earlier this month for a record-breaking $1.4 billion could change the…
Meeting News

Modeling demonstrates clinical, financial benefits of long-term treatment for NASH

July 22, 2019
SAN DIEGO – A treatment regimen that demonstrates lasting efficacy for patients with advanced non-alcoholic steatohepatitis would increase…

NAFLD, NASH leading 'economic tsunami' of liver disease in US

July 22, 2019
Stephen A. Harrison, MD, FACP, FAASLD, visiting professor of hepatology at University of Oxford and medical director at Pinnacle Clinical Research…

FDA approves application to expand Doptelet for autoimmune bleeding disorder

July 22, 2019
FDA approved a supplemental new drug application to expand the use of Doptelet to include the treatment of thrombocytopenia in adults with chronic…
In the Journals

Anti-TNF persistence lower among women with IBD

July 22, 2019
Higher rates of side effects lead to lower drug persistence of anti-TNF therapy among women with inflammatory bowel disease, according to study…

Colorectal cancer incidence among younger US adults continues to rise

July 22, 2019
Colorectal cancer diagnoses among individuals aged younger than 50 years continued to increase in the United States over the past decade, according…

NIH grant to fund research on microbiome’s role in cancer

July 20, 2019
A 5-year, $2.1 million grant from the NIH will support a CUNY Graduate School of Public Health & Health Policy-led study to identify the role the…
In the Journals

Depression linked to increased IBD activity

July 19, 2019
Researchers found that depression was independently associated with greater inflammatory bowel disease, or IBD, activity, and that less positive…

Best, brightest in GI to gather in Hollywood for GI Outlook

July 19, 2019
DOWNERS GROVE, Ill. — As the pace of change in U.S. health care continues to accelerate, gastroenterology physicians and practice managers…
At Issue

Should HAV vaccination be recommended for all adults?

Infectious Disease News, July 2019
In recent years, almost half of all U.S. states have reported outbreaks of person-to-person transmission of hepatitis A virus, especially among
Cover Story

HAV outbreaks prompt robust public health response

Infectious Disease News, July 2019
Much attention has been paid to hepatitis B and C viruses, as is evident from public health programs and the drug development pipeline. But three…
In the Journals

Concurrent NASH drives a ‘second hit’ to the liver in patients with HBV

July 19, 2019
Recent study data showed that concomitant chronic hepatitis B and nonalcoholic steatohepatitis were significantly more likely to lead to advanced…
In the Journals

Remicade has not produced expected reductions in IBD hospitalizations

July 19, 2019
The introduction of Remicade as a therapy for Crohn’s disease and ulcerative colitis has not reduced the rate of disease-related…
Profile

Corrona: Leveraging 'Big Data' for Improved Patient Outcomes

July 19, 2019
Most scientists, by nature and by training, are in one business: Observe a knowledge gap, and fill it. With that in mind, in 2001, the founders of…